-
12 Healthcare Stocks Moving In Tuesday's After-Market Session
2020 Oct 27, 4:47pm | 637Read More...Gainers Community Health Systems (NYSE:CYH) stock rose 6.93% to $4.7 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 81.2K shares, which is 5.35 percent of its average volume over the last 100 days. The market value of their outstanding...
-
BofA On Eli Lilly: Disappointing Q3 Comes In Otherwise Strong 2020
2020 Oct 27, 2:53pm | 223Read More...Eli Lilly And Co’s (NYSE: LLY) third-quarter results show the persisting impact of COVID-19 and pricing headwinds, according to BofA Securities. The Eli Lilly Analyst: Geoff Meacham maintained a Buy rating on Eli Lilly with a $180 price target. The Eli Lilly Thesis: The downbeat third-...
-
Exact Sciences Rallies On 2 M&A Deals In Cancer Screening Market
2020 Oct 27, 12:38pm | 566Read More...Shares of cancer screening and diagnostics company EXACT Sciences Corporation (NASDAQ: EXAS) were rallying to a record high Tuesday after it announced two M&A transactions and third-quarter results. Exact Sciences Strikes 2 Deals: Madison, Wisconsin-based Exact Sciences said it has...
-
Novavax Rallies On Phase 3 Coronavirus Study Updates, Imminent Phase 2 Readout
2020 Oct 27, 10:51am | 506Read More...Novavax, Inc. (NASDAQ: NVAX) issued an update Tuesday on a late-stage study of its coronavirus vaccine program, sending its shares higher. US Late-Stage Study Kicks Off In Late November: Gaithersburg, Maryland-based Novavax said it expects the Phase 3 trial of its coronavirus...
-
The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings
2020 Oct 27, 8:24am | 1868Read More...Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 26) Amicus Therapeutics, Inc. (NASDAQ: FOLD) Beam Therapeutics Inc (NASDAQ: BEAM) Blueprint Medicines Corp (NASDAQ: BPMC) EXACT Sciences Corporation (...
-
NIAID Study Finds Eli Lilly's Antibody Drug Unhelpful For Hospitalized COVID-19 Patients
2020 Oct 26, 11:02pm | 374Read More...Eli Lilly and Company (NYSE: LLY) said Monday that a trial of its antibody treatment for use in hospitalized COVID-19 patients has come to an end as the treatment is unlikely to help such patients. What Happened: The one of its kind study — conducted by the National Institute of Allergy...
-
12 Healthcare Stocks Moving In Monday's After-Market Session
2020 Oct 26, 4:41pm | 621Read More...Gainers Trxade Group (NASDAQ:MEDS) stock moved upwards by 31.29% to $8.14 during Monday's after-market session. Trxade Group's trading volume hit 636.9K shares by close, accounting for 1110.23% of its average volume over the last 100 days. The company's market cap stands at $62.6...
-
How Conversion Labs Is Building Its Telemedicine Business During COVID-19
2020 Oct 26, 3:19pm | 742Read More...Interest in telemedicine has soared during the coronavirus pandemic as health care patients sought continuity during the crisis by going virtual. That’s according to Conversion Labs Inc (OTCQB: CVLBD) CEO Justin Schreiber, who told Benzinga his business tripled as the coronavirus...
-
I No Longer Have Dental Benefits Through My Employer. Now What?
2020 Oct 26, 11:07am | 1738Read More...The economic impact of COVID-19 has left 6.2 million Americans, not counting their dependents, without health coverage, according to an estimate by The Economic Policy Institute. Roughly 90% of Americans with dental insurance are a member of a group plan, according to the National Association...
-
Life Insurance In The Time Of COVID-19
2020 Oct 26, 10:50am | 1125Read More...As coronavirus numbers across the U.S. are once again rising and uncertainty looms towards the upcoming election, more and more people are moving towards future financial protection for themselves and their families in the form of life insurance. With over 220,000 deaths and 8 million cases across...
-
ROCE Insights For TherapeuticsMD
2020 Oct 26, 10:01am | 274Read More...During Q2, TherapeuticsMD (NASDAQ: TXMD) brought in sales totaling $10.70 million. However, earnings decreased 11.55%, resulting in a loss of $45.04 million. TherapeuticsMD collected $12.25 million in revenue during Q1, but reported earnings showed a $50.92 million loss. Why ROCE Is Significant...
-
Overview Of Value Stocks In The Healthcare Sector
2020 Oct 26, 9:51am | 421Read More...Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock. The...
-
MMA Pro Elias Theodorou Keeps Fighting For Cannabis Rights
2020 Oct 25, 10:03am | 760Read More...Professional MMA fighter Elias Theodorou recently spoke with Benzinga about his efforts to fight the stigma against cannabis use and the uphill battle that comes with it. Related link: From Free Agent To Agent Of Change: Elias Theodorou's Cannabis Advocacy Has Changed The Game For Professional...
-
12 Healthcare Stocks Moving In Friday's Intraday Session
2020 Oct 23, 1:44pm | 647Read More...Gainers Adaptimmune Therapeutics (NASDAQ:ADAP) stock moved upwards by 13.95% to $4.9 during Friday's regular session. As of 12:31 EST, Adaptimmune Therapeutics's stock is trading at a volume of 1.8 million, which is 211.99% of its average full-day volume over the last 100 days. The market...
-
Cannabis, Period: Using Marijuana To Relieve Menstrual Symptoms
2020 Oct 23, 1:15pm | 1251Read More...This article was written by Marian Venini and originally published in El Planteo. It is no longer a secret that marijuana helps alleviate a plethora of conditions, from anxiety and depression to inflammation and muscle pain. Menstruation is no exception. Many menstruating folk use (and have used...
